Association of insulin with the plasma membrane of the pancreatic B-cell was revealed using the high-resolution protein A-gold immunocytochemical approach. The labeling was found to be heterogeneously distributed, the plasma membrane of the actin-rich miaovilli being preferentially labeled. Morphometrical evaluation of labeling intensities confirmed the miaovilli location of the insulin binding sites. This membrane domain, which also displays the glucose transporter,
Introduction
In the last decade, studies have been undertaken to evaluate the paracrine and autocrine influence of insulin on the different populations of pancreatic islet cells (1, 2) . Although the paracrine interaction of insulin on A-and D-cells has been established (1-5), conflicting evidence has been reported concerning the influence of insulin on its own secretion. Indeed, some studies do suggest that insulin exerts an autocrine effect on pancreatic B-cells (1, 2, (6) (7) (8) (9) (10) (11) (12) . Although no consensus has been reached (&lo). in vivo and in vitro studies have put forward data demonstrating that insulin inhibits its own secretion (1, 8, 11) . A heterogeneity in the secretory response among B-cells within the islets of Langerhans has been recently reported (13) . This, together with the demonstration of the particular vascularization within the islet (14) and surrounding parenchyma (15) (16) (17) , lends support to the fact that insulin discharged by centrally located B-cells could modulate the secretory activity of B and non-B peripheral islet cells as well as the peri-insular acinar parenchyma (18). The mechanism underlying the autocrine influence of insulin on its own secretory cell could be receptor mediated. The existence of insulin receptor at the level of the plasma membrane of islet cells has been reported only using in vitro systems of pancreatic cells (18-21), raising again debatable issues since in vivo experiments with radiolabeled insulin failed to demonstrate the presence of specific insulin receptors on B-cell plasma membrane (22, 23) . In the present study, we analyzed the labeling obtained using an anti-insulin antibody in conjunction with the protein A-gold immunocytochemical approach on pancreatic B-cells, focusing our attention on the labeling found at the level of the B-cell plasma membrane. The results obtained and assessed through morphometrical analysis have demonstrated that insulin immunolabeling does occur at the level of the plasma membrane of B-cells, revealing the existence of insulin binding sites. Furthermore, the distribution of that labeling was found to be preferentially located on actin-rich B-cell microvilli, attributing important roles to this particular membrane domain in the overall functional activities of the cell.
Materials and Methods
Pancreatic tissue from normal male Sprague-Dawley rats was fixed by immersion with 1% glutaraldehyde in 0.1 M phosphate buffer, post-fiied with 1oh osmium tetroxide, and embedded in Epon according to routine techniques. Tissue sections containing islets of Langerhans were selected and mounted on Parlodion-and carbon-coated nickel grids and processed for the protein A-gold immunolabeling with the anti-insulin antibody as described previously (24) . The anti-insulin antibody (Miles Biochem; Elkhart, IN) was diluted to 1:200, while the protein A-gold used was prepared with U-nm gold particles according to techniques detailed in previous studies (25, 26) . The tissue sections were pre-treated with a saturated solution of sodium metaperiodate for 1 hr at room temperature before the incubation with the anti-insulin, which lasted for 2 hr at room temperature. This was followed by a 30-min incubation with the protein A-gold complex, also at room temperature. After labeling, the sections were stained with uranyl acetate and lead citrate and examined with a Philips 410SL electron micro--.
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.. , -- Figure 1 . Section of rat pancreatic B-cells labeled for insulin by the protein A-gold immunocytochemical technique. The labeling by gold particles is present over the core of the secretory granules (G) of the B-cells as well as at the level of the plasma membranes (arrowheads). The plasma membrane of the microvilli (mv) appears to be labeled with higher intensity than the flat membrane facing the capillary vessel. Endocytotic coated pits and vesicles (large arrows) are also labeled. Some gold particles are found in the interstitial space and capillary lumen (CL). M, mitochondrion. Bar = 0.5 Um.
scope. For the morphometrical analysis, areas of B-cells were recorded at an original magnification of x 14,000 and enlarged to a final magnification of x 35,000. Fifty micrographs, originating from four different labeling experiments and comprising 36 different cell profiles, were included in the study. The density of insulin immunolabeling occurring at the level of the B-cell plasma membrane was analyzed by direct planimetry using a Videoplan 2 (Carl Zeiss; Montrtal, QuCbec, Canada). First. the length of the membrane was measured and then the number of gold particles aligned on that same membrane was counted. The density of labeling was calculated and expressed in number of gold particles per pm of membrane.
Two domains of the plasma membrane were selected and the evaluation was carried out separately. One domain corresponded to the flat membrane facing the blood capillaries. The other domain was the membrane lining the cytoplasmic projections facing either neighboring cells or blood capillaries. In addition, the labeling associated with the limiting membrane of the B-cell secretory granules was also evaluated, following the same protocol.
To assess the specificity of the labeling. the anti-insulin antibody was adsorbed with an cxcess of insulin for 4 hr at room temperature bcfore its use for immunolabeling. A second control was performed in which the specific anti-insulin was substituted by normal serum. Morphometrical evaluation of the density of the labeling associated with the B-cell plasma membrane. flat membrane, and microvilli domains under control conditions was also performed.
To clearly identify the nature of the cytoplasmic projections or microvilli, sections of islet tissues fixed with 1% glutaraldehyde and embedded in Lowicryl were labeled for actin as described previously (27) .
Results
Immunolabeling for insulin in B-cells was found in the various cell compartments involved in secretion, i.e., the rough endoplasmic reticulum, the Golgi apparatus, and the different types of secretory granules, as described in detail and morphometrically evaluated in a previous study (24). In addition, it clearly appeared that the plasma membrane of the B-cell was also labeled, although the number of gold particles overlying the membrane was not very high ( Figure 1 ). It was further found that this labeling was not uniform, the flat regions of the membrane being less labeled than those presenting cytoplasmic projections or microvilli (Figure 1) . The microvilli are thin cytoplasmic projections that were found to have an actin-rich core and were devoid of secretory granules (Figure 2) . Coated pits and vesicles located at or close to the plasma membrane were also labeled for insulin ( Figure 1 ). Specific labeling, although of low intensity, was registered in the connective tissue between B-cells or underlying the islet capillaries, as well as within endothelial cells and capillary lumina (Figure 1 ). Under the control condition, in which the antibody was adsorbed with its own antigen, the labeling was practically abolished at the level of the plasma membrane and was significantly reduced in the secretory granules, as reported previously (24). Substitution of the anti-insulin by normal serum resulted in the presence of very few gold particles scattered throughout the tissue. The morphometrical evaluation of the insulin immunolabeling present at the plasma membrane confirmed the subjective observation and demonstrated that the labeling of the B-cell microvilli membrane is several-fold higher than that present on the flat domain of the membrane (Table 1 ). In addition, it also demonstrated the very low labeling obtained under the control condition. No significant difference was found between the labelings obtained on the flat domain of the plasma membrane in specific and control conditions. On the other hand, the density of labeling associated with the limiting membrane of the secretory granules was found to be 0.14 k 0.03 particles per pm (106 pm of secretory granules limiting membrane evaluated), a value very similar to that found for the flat domain of the membrane (0.12 2 0.05).
To characterize the nature of the microvilli, actin antigenic sites were revealed in the B-cell. Actin immunolabeling was found in the B-cell cytoplasm, particularly at the level of the cell web and associated with the limiting membrane of the secretory granules, as reported in detail previously (27) . In addition, specific labeling was found over the cytoplasmic projections, demonstrating the actin nature of the core of these structures and designating them as microvilli (Figure 2 ). 
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Discussion
The present results demonstrate the presence of specific insulin labeling at the level of the B-cell plasma membrane. This labeling did not occur in a random fashion but rather was concentrated in a particular domain of the membrane, the microvilli. In addition to the results obtained under control conditions, this heterogenous distribution of insulin labeling over the plasma membrane speaks in favor of its specificity, since an artifactual adsorption of secreted insulin on the closest membrane occurring during the fixation process would have led to a random distribution of the labeling. On the other hand, we cannot rule out the fact that the microvillar regions delineate extracellular pocket-like areas where secreted insulin could be trapped for a certain length of time, leading to high concentrations and a certain binding to the microvillar membrane. Kaplan et al. (28) have previously reported the existence of insulin immunoreactivity at the level of the B-cell plasma membrane, using the immunofluorescence approach. Light microscopy yields results of low resolution, impairing the demonstration of labeling in particular membrane domains. Their study led them to the conclusion that the insulin revealed on the B-cell plasma membrane originates from the intracellular binding of insulin to the limiting membrane of the cell compartments involved in secretion, in particular to that of the granules. In such a case, insulin would become associated with the B-cell plasma membrane at the time of insulin discharge, during fusion of the granules with the plasma membrane. Our results do not support such a proposition, since the labeling was concentrated in a particular domain of the plasma membrane and was not random. Furthermore, the intensity of labeling obtained for insulin over the limiting membrane of secretory granules was found to be similar to that of the flat domain of the plasma membrane, where in fact it is remarkably low. Major dissimilarities in the technical protocols among both studies, in particular the use of pre-embedding labeling on isolated pancreatic cells (28) vs the present post-embedding labeling on intact tissue and differences in resolution, may explain the discrepancies in results.
The preferential labeling of microvilli demonstrates that the plasma membrane of the B-cell is specialized in different functions. Sussman, in 1989 (I), postulated that if insulin binding sites exist in B-cells they must occur in discrete domains of the plasma membrane where insulin secretion could not take place. The present result seems to confirm that prediction, since the microvilli, owing to their structure, are indeed regions where discharge of granules could be quite difficult, and no granules are found in the core of the microvilli. Further along this line, it has been demonstrated that the microvilli display another important functional protein, the glucose transporter (29) . Indeed, the liver-type glucose transporter is present in B-cell plasma membrane, concentrated in the microvilli domain (29) . That both the insulin binding site and the glucose transporter share the same location could be crucial for the optimalization of B-cell function. On the other hand, the partition of the plasma membrane into different functional domains goes along with the polarization of the secretory activity of the cell. Concentration of secretory granules and discharge activities take place in the apical region of the cell facing the blood capillaries (30), whereas the presence of sensor molecules, insulin binding sites, and glucose transporter appears to occur in the microvillar domain.
The present study has also clarified the nature of the cytoplasmic projections or microvilli which do contain an actin-rich core. Microvilli have been generally described in highly polarized cells as being restricted to the apical luminal membrane, as is the case for intestinal and renal epithelial cells. In the present study, we have a unique case in which typical actin-rich microvilli are, in fact, projecting into the interstitial space. As for luminal microvilli, these interstitial microvilli enhance the plasma membrane surface, favoring interactions with the extracellular milieu.
Previous studies have demonstrated the specific binding of insulin to the plasma membrane of B-cells (28, 31) . Although not demonstrated, this binding could well correspond to the specific insulin receptor. Such a receptor has been reported in in vitro systems of islet cells (19-21) but was not detected in in vivo experiments with radiolabeled insulin (22,23) . The fact that large amounts of insulin are present in the interstitial space around the B-cell and in the islet capillaries (32) could easily explain technical difficulties in labeling insulin receptors in B-cells by in vivo perfusion of radiolabeled insulin and application of the autoradiographic technique. That the labeling reported in the present study reflects the binding of insulin to its own receptor, thus influencing its own secretion, remains, however, to be demonstrated.
